What you might be experiencing
Psychedelic-assisted therapy for depression tends to attract serious attention from people who have been through multiple treatments — medications that blunted things without fixing them, therapy that helped some but not enough, or both — and are still not well. That kind of persistent suffering is real, and it makes sense that you would look further.
What the research has captured, and what people describe from clinical trials, is not simply a temporary mood lift. Some participants report a shift in the way they relate to their own thoughts and feelings — a loosening of rigid mental patterns that depression tends to reinforce. But these experiences happen within a structured therapeutic context, with preparation beforehand and integration support afterward. That container matters. The substance alone is not the treatment.
It is also worth knowing that not everyone responds positively, and for some people the experience is destabilizing rather than helpful. If you have a personal or family history of psychosis, bipolar disorder, or certain other conditions, that risk is meaningfully higher — which is exactly why clinical screening exists.
What can help
Before pursuing psychedelic-assisted therapy for depression, the most useful step is a honest review of what you have already tried — with a clinician who can evaluate it clearly. This means looking at whether therapy was the right type and lasted long enough, whether medications were tried at adequate doses and durations, and whether lifestyle factors were addressed. 'Treatment-resistant' has a specific clinical meaning, and that determination shapes what options are medically appropriate next.
If you and your care team conclude that standard approaches have not been sufficient, there are legally available options worth exploring. Esketamine (a nasal spray derived from ketamine) is FDA-approved for treatment-resistant depression and administered in supervised clinical settings. Psilocybin-assisted therapy is legal for therapeutic use in Oregon and Colorado, and a small number of licensed clinical research trials are accessible in other states. These programs include screening, preparation sessions, a supervised experience, and follow-up integration — all of which affect outcomes. A one-time unsupervised experience is a different thing entirely and carries different risks.
Your current medications also matter. Some interact directly with psychedelic substances, and that review needs to happen with a prescriber before any next step.
When to reach out
Getting a professional opinion before pursuing any experimental treatment is not a bureaucratic hurdle — it is how you find out whether a given approach is actually safe for your specific history. A psychiatrist or psychiatric nurse practitioner is the right starting point, particularly if you are considering any changes to current medications or exploring programs that involve medical screening.
Some signs that professional support is especially urgent: your depression has worsened recently, you are having thoughts of suicide or self-harm, you are experiencing symptoms that feel like losing touch with reality, or you are considering using substances outside of any supervised program. None of these situations are ones to navigate alone, and none of them are appropriate starting points for psychedelic exploration.
If you are in the US and need immediate support, you can call or text 988 (Suicide & Crisis Lifeline) at any time. If you are in acute crisis, an emergency room is the right place, not an experimental treatment program.